(AHL) Aspen Insurance Holdings - Ratings and Ratios
Reinsurance, Insurance, Property, Casualty, Specialty
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 2.58% |
| Value at Risk 5%th | 4.06% |
| Relative Tail Risk | -4.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 10.52 |
| CAGR/Max DD | 1.00 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.656 |
| Beta | -0.017 |
| Beta Downside | -0.092 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.85% |
| Mean DD | 4.77% |
| Median DD | 0.24% |
Description: AHL Aspen Insurance Holdings November 14, 2025
Aspen Insurance Holdings Ltd. (NYSE:AHL) operates a diversified insurance and reinsurance platform across Australia, Asia, Europe, North America and other international markets. Through its subsidiaries, the firm underwrites property catastrophe, casualty, specialty and retrocession reinsurance, as well as first-party, professional lines, and specialty insurance, primarily distributing these products via brokers and reinsurance intermediaries.
Key performance indicators to watch include the combined ratio (target < 95 % for underwriting profitability), net written premiums (≈ $3.1 bn in 2023), and return on equity (ROE ≈ 8 %). The business is highly sensitive to natural-catastrophe cycles, global interest-rate environments (which affect investment income), and the broader hard-soft reinsurance pricing cycle that typically spans 5-7 years.
For a deeper quantitative view, you might explore ValueRay’s analyst tools to assess Aspen’s valuation dynamics.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (453.9m TTM) > 0 and > 6% of Revenue (6% = 192.5m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.66pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 356.8% (prev 235.2%; Δ 121.6pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 311.7m <= Net Income 453.9m (YES >=105%, WARN >=100%) |
| Net Debt (-830.2m) to EBITDA (511.3m) ratio: -1.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 11.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (92.0m) change vs 12m ago 52.37% (target <= -2.0% for YES) |
| Gross Margin 35.37% (prev 30.77%; Δ 4.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 19.74% (prev 18.78%; Δ 0.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 12.92 (EBITDA TTM 511.3m / Interest Expense TTM 38.2m) >= 6 (WARN >= 3) |
Altman Z'' 5.38
| (A) 0.70 = (Total Current Assets 12.59b - Total Current Liabilities 1.14b) / Total Assets 16.41b |
| (B) 0.13 = Retained Earnings (Balance) 2.20b / Total Assets 16.41b |
| (C) 0.03 = EBIT TTM 493.7m / Avg Total Assets 16.26b |
| (D) 0.15 = Book Value of Equity 1.98b / Total Liabilities 12.94b |
| Total Rating: 5.38 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.39
| 1. Piotroski 4.0pt |
| 2. FCF Yield 14.46% |
| 3. FCF Margin 8.91% |
| 4. Debt/Equity 0.09 |
| 5. Debt/Ebitda -1.62 |
| 6. ROIC - WACC (= 7.83)% |
| 7. RoE 13.57% |
| 8. Rev. Trend 65.50% |
| 9. EPS Trend -53.25% |
What is the price of AHL shares?
Over the past week, the price has changed by +0.43%, over one month by +0.65%, over three months by +1.31% and over the past year by +14.46%.
Is AHL a buy, sell or hold?
What are the forecasts/targets for the AHL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.6 | 9.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 38.9 | 4.4% |
AHL Fundamental Data Overview January 03, 2026
P/E Trailing = 4.8678
P/S = 0.8787
P/B = 1.1062
Beta = None
Revenue TTM = 3.21b USD
EBIT TTM = 493.7m USD
EBITDA TTM = 511.3m USD
Long Term Debt = 296.6m USD (from longTermDebt, last quarter)
Short Term Debt = 15.4m USD (from shortTermDebt, last fiscal year)
Debt = 296.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -830.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.98b USD (2.81b + Debt 296.6m - CCE 1.13b)
Interest Coverage Ratio = 12.92 (Ebit TTM 493.7m / Interest Expense TTM 38.2m)
FCF Yield = 14.46% (FCF TTM 285.9m / Enterprise Value 1.98b)
FCF Margin = 8.91% (FCF TTM 285.9m / Revenue TTM 3.21b)
Net Margin = 14.15% (Net Income TTM 453.9m / Revenue TTM 3.21b)
Gross Margin = 35.37% ((Revenue TTM 3.21b - Cost of Revenue TTM 2.07b) / Revenue TTM)
Gross Margin QoQ = 40.99% (prev 34.32%)
Tobins Q-Ratio = 0.12 (Enterprise Value 1.98b / Total Assets 16.41b)
Interest Expense / Debt = 3.07% (Interest Expense 9.10m / Debt 296.6m)
Taxrate = 21.69% (33.8m / 155.8m)
NOPAT = 386.6m (EBIT 493.7m * (1 - 21.69%))
Current Ratio = 11.06 (Total Current Assets 12.59b / Total Current Liabilities 1.14b)
Debt / Equity = 0.09 (Debt 296.6m / totalStockholderEquity, last quarter 3.47b)
Debt / EBITDA = -1.62 (Net Debt -830.2m / EBITDA 511.3m)
Debt / FCF = -2.90 (Net Debt -830.2m / FCF TTM 285.9m)
Total Stockholder Equity = 3.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.77% (Net Income 453.9m / Total Assets 16.41b)
RoE = 13.57% (Net Income TTM 453.9m / Total Stockholder Equity 3.35b)
RoCE = 13.56% (EBIT 493.7m / Capital Employed (Equity 3.35b + L.T.Debt 296.6m))
RoIC = 13.44% (NOPAT 386.6m / Invested Capital 2.88b)
WACC = 5.61% (E(2.81b)/V(3.10b) * Re(5.95%) + D(296.6m)/V(3.10b) * Rd(3.07%) * (1-Tc(0.22)))
Discount Rate = 5.95% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 23.44%
[DCF Debug] Terminal Value 74.10% ; FCFE base≈326.5m ; Y1≈254.7m ; Y5≈164.6m
Fair Price DCF = 33.49 (DCF Value 3.08b / Shares Outstanding 91.8m; 5y FCF grow -26.18% → 3.0% )
EPS Correlation: -53.25 | EPS CAGR: -81.89% | SUE: N/A | # QB: 0
Revenue Correlation: 65.50 | Revenue CAGR: 10.39% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=5.11 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+41.8% | Growth Revenue=+5.5%
Additional Sources for AHL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle